Fab Biopharma’s Post

After a successful Women in Advanced Therapies Global, What's next for Phacilitate? - 10th September (Estoril, Portugal) Women in Advanced Therapies Congress (Europe) Advanced Therapies Investment Summit (Europe) - 10-11-12th September (Estoril, Portugal) Advanced Therapies Europe - 20-21-22-23rd January 2025 (Dallas, Tx) Advanced Therapies Week #Phacilitate #AdvancedTherapiesWeek #AdvancedTherapiesEurope #ATW25 #ATE24 #celltherapy #genetherapy #cellandgenetherapies #ATMPs #AdvancedTherapies

Looking forward to joining fellow industry leaders at this year’s IDDST-International Drug Discovery Sciences & Technology Congress in Budapest! I am particularly excited to discuss how drug development in women’s health can uniquely leverage female biology to customize delivery methods and durations for optimized outcomes. If you are attending or will be in the area, let’s connect and talk all things #womenshealth!

Imagine a future where treatments are tailored to each patient's unique genetic makeup. This future is rapidly becoming a reality thanks to advancements in pharmacogenomics. By leveraging AI-powered analysis, healthcare providers can now predict drug responses, minimise adverse effects, and optimise treatment plans. As this field continues to evolve, personalised, precision-based therapies are poised to transform healthcare. Read more about how pharmacogenomics is shaping the future of medicine. 👇 #PrecisionMedicine #Pharmacogenomics #AIinHealthcare #PersonalisedTreatment #FutureOfHealthcare #DrugDevelopment #PatientOutcomes

🌍 💊 Understanding the genetic differences in how medications affect diverse populations is crucial for personalized healthcare. Localized medical research plays a pivotal role in uncovering these nuances, especially in pharmacogenetics. Different ethnicities can react differently to drugs due to genetic predispositions, influencing everything from drug absorption to side effects. Take warfarin, for instance - a commonly prescribed blood thinner. Its effectiveness and safe dosage vary among individuals of different ethnic backgrounds. By supporting local medical research, we support to ensure that healthcare adapts to the unique genetic makeup of our communities, enhancing treatment outcomes and patient safety. Let's advocate for inclusive research that reflects our diverse world! 🌏 💉 #futuremed #venturecapital

Nothing is more inspiring than to meet the Nobel Laureate Dr. Katalin Karikó, who was able to overcome many challenges, and at the end, she helped humanity to overcome its biggest health crisis. This month was transformational. I was able to share with extraordinary women scientist my biggest concerns about the future of our global healthcare, and receive reassurance that help is on the way. There are over 160 on-going clinical programs, using her discoveries, to overcome major diseases. It provided me with renewed hope, and yet I immediately realized that we will need all the help we can get to launch them as quickly as possible. One...six...zero - that's a lot of launches to shape, educate, and guide the market on the best way to adopt new treatments. It takes time, resources, and access. Patients are waiting. #discoveries, #innovation, #reserchanddevelopment, #biotechnology, #pharmaceuticals, #globalhealth

Feeling energized with this week’s discussions in #Basel! I had the privilege to present on "Incentivising Funding for Women’s Health Innovation: Adopting a Framework from the Orphan Drug Model" at the #WHISEU which we collaborative wrote at Catenion with Dr. Ilkin Nehls and Dr. Pascal Joly. Some quick key takeaways from the talk and following discussions: 🔍 Broadening the Scope of Women's Health: Women's health encompasses more than just diseases unique to females. It's about recognizing that every disease affecting a woman requires tailored approaches. Adopting a personalized medicine model with sex as a crucial factor is pivotal. 💡 Innovation Beyond Pharmaceuticals: Innovation in women's health extends beyond New Biological Entities (NBEs) and New Chemical Entities (NCEs). It involves bridging research gaps, addressing translational challenges, and enhancing regulatory clarity and endpoints. 💰 Pathways to Funding Innovation: Developing a sustainable funding model needs a blend of policy incentives, public funding, and compelling business cases tailored for both governmental and private investors. Engaging with stakeholders like patient organizations, policymakers, and political representatives is key for driving change - check the learnings from the successful model of orphan drug development (happy to discuss further) 🚀 Envisioning a future where women's health R&D thrives requires regulatory incentives and guidelines that break silos for translational research. This could involve measures like mandatory sex-segregated reporting of results, simplified regulatory submissions, expedited pathways for innovation, extended patent life, etc. For more insights, check out our article: https://lnkd.in/dQQmgrVH A huge thank you to Women's Health Innovation Series for the invitation, and to all participants for the enriching discussions over the two days. Special thanks to my amazing colleagues Pascal Joly and Ilkin Nehls from Catenion for the collaborative work everyday. Looking forward to continuing the conversation and addressing some thought-provoking questions (maybe in future posts)! Feel free to reach out for further discussions. #WomensHealth #Innovation #WHISEU #catenion #biopharmaconsulting

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝘄𝗶𝘁𝗵 𝗜𝗻 𝗦𝗶𝗹𝗶𝗰𝗼 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 Despite significant strides in women’s health research, gaps still remain in understanding how medications affect women differently. This is especially true for pregnant and lactating women, who are often excluded from clinical trials. InSilicoTrials is at the forefront of addressing this issue through advanced modeling and simulation techniques. By leveraging population 𝗣𝗞/𝗣𝗗, 𝗣𝗕𝗣𝗞, and 𝗤𝗦𝗣 𝗺𝗼𝗱𝗲𝗹𝗶𝗻𝗴, we can: - 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗲 𝗱𝗿𝘂𝗴 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻𝘀 with women's unique physiology. - 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗽𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀 for conditions like hormonal cycle-related disorders. - 𝗜𝗻𝗰𝗹𝘂𝗱𝗲 𝘄𝗼𝗺𝗲𝗻 𝗶𝗻 𝘃𝗶𝗿𝘁𝘂𝗮𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 to ensure their specific needs are met. Let's work together to bridge the gender gap in healthcare and improve women's health outcomes. Discover more about this crucial topic in our new white paper, '𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝘄𝗶𝘁𝗵 𝗜𝗻 𝗦𝗶𝗹𝗶𝗰𝗼 𝗗𝗲𝘀𝗶𝗴𝗻 𝗮𝗻𝗱 𝗘𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀'. Dive into how advanced simulations are reshaping research and treatment protocols to address the unique healthcare needs of women. Read the white paper here: https://lnkd.in/eFXqpy7w #womenshealth #drugdevelopment #insilicotrials #modelingandsimulation #healthcareinnovation #pharma #biotech

Improving #diversity in #clinicaltrials is crucial for ensuring that medical treatments are effective and safe for all populations, as differences in genetic makeup, lifestyle, and environmental factors can significantly impact treatment outcomes. To learn more, check out this infographic! → Clinical trials are essential to assessing safety and efficacy of new therapeutics. → Many trials fail to engage participants representative of the health concern being studied. → The resulting findings are often not generalizable and fail to equitably benefit all groups.

This brief video introduces the objectives of our #ResonateHorizonEurope project on nature-based therapies. Read more about the project at https://lnkd.in/eD66TZAy. #research #NbT #publichealth #Europe

Ethical Innovation at the Heart of Healthcare Ethical considerations are at the core of everything we do at Accelerated Biosciences. We are committed to advancing regenerative medicine responsibly, with a steadfast dedication to ethical sourcing and application of human Trophoblast Stem Cells (hTSCs). Our ethical commitment goes beyond compliance—it is about respect for life and potential. We ensure that all our stem cells are sourced and utilized in ways that are not only scientifically sound but also morally justifiable. This commitment to ethics not only reinforces our leadership in the industry but also builds trust with our partners, patients, and the broader community. At Accelerated Biosciences, we believe that true innovation in healthcare doesn't just solve problems—it does so with integrity. Stay connected with us to see how we're setting new standards in the ethical development of life-saving therapies. #EthicalResearch #RegenerativeMedicine #StemCellEthics #HealthcareInnovation #TrustInScience